TOPIGEN Pharmaceuticals, Inc., a biopharmaceutical company specializing in innovative respiratory therapeutics, today announced the appointment of Dr. Mitchell Glass to its Scientific Advisory Board (SAB). Dr. Glass is a pulmonary and critical care specialist and recognized expert in developing drug products for pulmonary and inflammatory-related disorders.
